Better Therapeutics (BTTX) director Armanino bought 25,000 shares for $41.4K at $1.65

Insider transactions reported

Andrew J. Armanino (director at Better Therapeutics Inc., BTTX) reported that they bought 25,000 shares for $41.4K at $1.65 on Jun 9, 2022. After these transactions the filing shows 151,328 shares held indirectly (By Armanino Trust).

Reporting person

Armanino Andrew J.

Options and other derivatives

Holdings before and after

• Common Stock: 126,328 to 151,328 indirect, By Armanino Trust
• Stock Option (Right to Buy): 0 to 15,000 direct

Other positions listed

• Common Stock: 13,334 direct

Footnotes from the filing

1. 1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6475 to $1.6791, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
2. 2. These shares are owned directly by the Andrew J. Armanino III and Denise M. Armanino Family Trust (the Armanino Trust ), and indirectly by the Reporting Person and his spouse, Denise M. Armanino, as trustees of the Armanino Trust.
3. 3. The stock option vests in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director of the Issuer on such vesting date. The stock option was granted on June 9, 2022.

Transaction codes in this filing

Open-market purchase:

Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

FAQ